​

Silence Therapeutics Ownership | Who Owns Silence Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Silence Therapeutics Ownership Summary

Silence Therapeutics is owned by 44.92% institutional investors, 24.38% insiders, and 30.71% retail investors. Nantahala capital management is the largest institutional shareholder, holding 9.80% of SLN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 1.36% of its assets in Silence Therapeutics shares.

SLN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSilence Therapeutics44.92%24.38%30.71%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nantahala capital management1.54M9.80%$9.38M
Tcg crossover management3.03M6.42%$15.74M
Artal group2.78M6.32%$52.81M
Siren2.91M6.16%$15.11M
Redmile group2.16M4.58%$11.24M
Lombard odier asset management (usa)1.84M3.91%$7.12M
Vivo capital1.11M2.34%$5.74M
Morgan stanley324.63K2.06%$1.97M
Nextech invest952.40K2.02%$4.94M
Ikarian capital900.78K1.91%$1.31M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
M28 capital management lp185.10K1.41%$960.67K
Artal group2.78M1.35%$52.81M
Redmile group2.16M1.09%$11.24M
Nextech invest952.40K1.06%$6.55M
5am venture management476.20K0.91%$2.47M
Tcg crossover management3.03M0.77%$15.74M
Nextech invest952.40K0.75%$4.94M
Siren2.91M0.59%$15.11M
Lombard odier asset management (usa)1.84M0.48%$7.12M
Vivo capital1.11M0.46%$5.74M

Top Buyers

HolderShares% AssetsChange
Nantahala capital management1.54M0.31%500.00K
Citadel advisors116.76K0.00%74.08K
Jane street group29.17K-29.17K
Ikarian capital900.78K0.13%27.22K
Boothbay fund management279.64K0.02%27.22K

Top Sellers

HolderShares% AssetsChange
Lombard odier asset management (europe)---2.24M
Janus henderson group---1.09M
Polar capital---1.00M
Deep track capital, lp---1.00M
Frazier life sciences management---970.13K

New Positions

HolderShares% AssetsChangeValue
Global retirement partners1.00K0.00%1.00K$6.08K
Rockefeller capital management45.00-45.00$234.00

Sold Out

HolderChange
Eversource wealth advisors-10.00
Principal securities-17.00
Lazard asset management-60.00
Values first advisors-3.09K
Acadian asset management-4.22K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202527-50.00%7,072,071-64.11%442.58%13-38.10%8-50.00%
Sep 30, 202553-7.02%16,670,893-15.69%3518.12%21-8.70%16-15.79%
Jun 30, 202556-6.67%19,736,025-7.96%136.08%22-8.33%19-24.00%
Mar 31, 202560-9.09%21,913,755-11.60%154.95%23-39.47%2592.31%
Dec 31, 202461-14.08%21,582,466-23.46%150.42%35-5.41%12-20.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I640.00K1.36%-
MEDICAL BioHealth EUR Acc528.12K1.12%359.90K
Polar Capital Biotech S Inc467.15K0.99%-532.85K
International Biotechnology Ord442.90K0.94%-
apo Medical Opportunities R228.31K0.48%111.89K
iShares Biotechnology ETF144.23K0.31%144.23K
T. Rowe Price Health Sciences95.65K0.20%95.65K
RIM Global Bioscience EUR94.16K0.20%-
BIT Biotech Opportunities S92.43K0.20%-14.87K
Tema Obesity & Cardiometabolic ETF76.77K0.16%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 27, 2025Griffiths Richard Ian-Buy$15.50K
Aug 03, 2025Griffiths Richard Ian-Buy$109.00K
Oct 27, 2025Griffiths Richard Ian-Buy$15.50K
Aug 03, 2025Griffiths Richard Ian-Buy$109.00K
Aug 01, 2025Griffiths Richard Ian-Buy$24.77K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q311-
2025 Q237-
2025 Q113-

SLN Ownership FAQ

Who Owns Silence Therapeutics?

Silence Therapeutics shareholders are primarily institutional investors at 44.92%, followed by 24.38% insiders and 30.70% retail investors. The average institutional ownership in Silence Therapeutics's industry, Biotech Stocks , is 381.47%, which Silence Therapeutics falls below.

Who owns the most shares of Silence Therapeutics?

Silence Therapeutics’s largest shareholders are Nantahala capital management (1.54M shares, 9.80%), Tcg crossover management (3.03M shares, 6.42%), and Artal group (2.78M shares, 6.32%). Together, they hold 22.54% of Silence Therapeutics’s total shares outstanding.

Does Blackrock own Silence Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Silence Therapeutics.

Who is Silence Therapeutics’s biggest shareholder by percentage of total assets invested?

M28 capital management lp is Silence Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.41% of its assets in 185.1K Silence Therapeutics shares, valued at 960.67K$.

Who is the top mutual fund holder of Silence Therapeutics shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Silence Therapeutics shares, with 1.36% of its total shares outstanding invested in 640K Silence Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools